Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Proschan

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2021
Reply to Chandereng and ChappellMichael Proschan, Scott Evans
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Two Stage Designs for Phase III Clinical TrialsDean Follmann, Michael Proschan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2020
Resist the Temptation of Response-Adaptive RandomizationMichael Proschan, Scott Evans
Journal of Multivariate Analysis|November 30, 2011
A test of location for exchangeable multivariate normal data with unknown correlationDean Follmann, Michael Proschan
Statistics in Medicine|January 30, 2015
Two-part test of vaccine effectZonghui Hu, Michael Proschan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2020
Reply to Villar et alMichael Proschan, Scott Evans
Journal of the American College of Cardiology|April 20, 2004
The metabolic syndromeMichael Domanski, Michael Proschan
Statistics in Medicine|June 28, 2007
Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trialsMichael Proschan, Dean Follmann
Contemporary Clinical Trials|August 12, 2014
On the design and analysis of clinical trials with correlated outcomesDean Follmann, Michael Proschan
The Lancet. Respiratory Medicine|September 15, 2022
Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?Andre C Kalil, Michael Proschan
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2021
Reply to Chandereng and ChappellMichael Proschan, Scott Evans
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Two Stage Designs for Phase III Clinical TrialsDean Follmann, Michael Proschan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2020
Resist the Temptation of Response-Adaptive RandomizationMichael Proschan, Scott Evans
Journal of Multivariate Analysis|November 30, 2011
A test of location for exchangeable multivariate normal data with unknown correlationDean Follmann, Michael Proschan
Statistics in Medicine|January 30, 2015
Two-part test of vaccine effectZonghui Hu, Michael Proschan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2020
Reply to Villar et alMichael Proschan, Scott Evans
Journal of the American College of Cardiology|April 20, 2004
The metabolic syndromeMichael Domanski, Michael Proschan
Statistics in Medicine|June 28, 2007
Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trialsMichael Proschan, Dean Follmann
Contemporary Clinical Trials|August 12, 2014
On the design and analysis of clinical trials with correlated outcomesDean Follmann, Michael Proschan
The Lancet. Respiratory Medicine|September 15, 2022
Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?Andre C Kalil, Michael Proschan
Pageof 6